The international market for Vitamin B12 which is a key ingredient in the pharmaceutical and nutraceutical industries has experienced a sharp decline in March due to excess stocks and muted demand from major industries. The fact that there was excess stock available from earlier purchases combined with a seasonal dip in demand after winter has resulted in Vitamin B12 price decline in major countries.

During March, Vitamin B12 prices declined moderately but effectively with cuts recorded across main exporting and importing destinations. Prices dipped between 0.5% and 1% in top world markets such as USA, China, India and Germany. This low percentage translates to a very serious monetary movement based on the fact that Vitamin B12 commands a high price tag. The Vitamin B12 price range differed in various market signalling a widespread market correction.

ChemAnalyst tracked that the drop in Vitamin B12 prices is due to a number of related market forces. In expectation of slowing production during Chinese Lunar New Year, many purchasers procured Vitamin B12 in advance during the last couple of weeks which resulted to a stock surplus. Upon the return to normal production levels, the Vitamin B12 supply outstripped its market demand. This further created a downward pressure on prices. Moreover, seasonal flu normally calls for increased demand for Vitamin B12-based medication and supplements in winter. But as the seasonal demand faded, the market underwent a natural normalization adding to the price decline.

Looking ahead, the Vitamin B12 market is likely to see an upward price adjustment in the coming months due to likely increase in demand as inventories are utilized. A more balanced supply-demand dynamic is expected to support price stabilization. Furthermore, suppliers are likely to modify pricing strategies to maintain market equilibrium and prevent further depreciation.

ChemAnalyst suggests that both suppliers and buyers to be on their toes as Vitamin B12 is a key raw material in the pharmaceutical and nutraceutical industries and captures a huge end user market. Suppliers of Vitamin B12 should focus more on strategic inventory management and monitoring of markets to predict changes in demand. While buyers and procurement specialists should try to capitalize on the prevailing low prices while being aware of the possibility of a rebound. Industry players must vigilantly monitor worldwide trade policies related to Vitamin B12 and quarterly demand fluctuations in order to effectively make procurement-related decisions. While the Vitamin B12 market unfolds, keeping informed about real-time market trends remains crucial for tactical decision-making across this high-margin industry.